Cardiff Oncology, Inc. - CRDF

SEC FilingsOur CRDF Tweets

About Gravity Analytica

Recent News

  • 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 08.28.2025 - Cardiff Oncology to Participate in Three Upcoming Investor Conferences
  • 08.28.2025 - Cardiff Oncology to Participate in Three Upcoming Investor Conferences
  • 07.29.2025 - CRDF-004 First-Line RAS-mutated mCRC Trial Update
  • 07.29.2025 - CRDF-004 First-Line RAS-mutated mCRC Trial Update
  • 07.29.2025 - Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
  • 07.29.2025 - Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
  • 07.29.2025 - Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
  • 07.29.2025 - Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update

Recent Filings

  • 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 07.31.2025 - 4 Statement of changes in beneficial ownership of securities
  • 07.29.2025 - 8-K Current report
  • 07.29.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 07.29.2025 - EX-99.1 EX-99.1
  • 07.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors